Dopamine infusion enhances the adrenocorticotropic hormone and Cortisol response to metoclopramide in hyperprolactinemic patients but not in normal subjects

References

• Kooy A., De Greef W. J., Vreeburg J. T. M., Hackneg W. H. L., Ooms M. P., Lamberts S. W. J., Weber R. F. A. Evidence for the involvement of corticotropin-releasing factor in the inhibition of gonadotropin release induced by hyperprolactinemia. Neuroendocrinology 1990; 51: 261–6
   Google Scholar
• Taya K., Sasamoto S. Inhibitory effects of corticotropin-releasing factor and b˜-endorphin on LH and FSH secretion in the lactating rat. J. Endocrinol. 1989; 120: 509–15
   PubMedGoogle Scholar
• Vanvugt D. A., Webb M. Y., Reid R. L. Naloxone antagonism of corticotropin-releasing hormone stimulation of prolactin secretion in rhesus monkeys. J. Clin. Endocrinol. Metab. 1989; 68: 1060–6
   Google Scholar
• Morel G., Enjalbert A., Proulx L., Pelletier G., Barden N., Grossard F., Dubois P. M. Effect of corticotropin-releasing factor on the release and synthesis of prolactin. Neuroendocrinology 1989; 49: 669–75
   Google Scholar
• Weber R. F. A., Calogero A. E. Prolactin stimulates rat hypothalamic corticotropin-re-leasing hormone and pituitary adrenocorticotropin secretion in vitro. Neuroendocrinology 1991; 54: 248–53
   PubMedGoogle Scholar
• Naylor A. M., Porter D. W. F., Lincoln D. W. Central administration of corti-cotropin-releasing factor in the sheep: effects on secretion of gonadotropins, prolactin and Cortisol. J. Endocrinol. 1990; 124: 117–25
   PubMed Web of Science ®Google Scholar
• Rivier C., Vale W. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat. J. Clin. Invest. 1985; 75: 689–94
   Google Scholar
• Comtois R., Beauregard H., Hardy J., Robert F., Somma M. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma. Clin. Endocrinol. 1993; 38: 601–7
   Google Scholar
• Calogero A. E., Weber R. F. A., Raiti F., Bur-rello N., Moncada M. L., Mongioi A., D'Agata R. Involvement of corticotropin-releasing hormone and endogenous opioid peptides in prolactin-suppressed gonadotropin-releasing hormone release in vitro. Neuroendocrinology 1994; 60: 291–6
   Google Scholar
• Klemcke H. G. Effects of bromocriptine-induced hypoprolactinemia on porcine adrenocortical adrenocorticotropic hormone (ACTH) receptors. 12nd Annual Meeting of the Endocrine Society 1990; 232: 82, Atlanta
   Google Scholar
• Higuchi K., Nawata H., Maki T., Higashizima M., Kato K., Ibayashi H. Prolactin has a direct effect on adrenal androgen secretion. J. Clin. Endocrinol. Metab. 1984; 59: 714–18
   PubMed Web of Science ®Google Scholar
• Albertson B. D., Sienkiewicz M. L., Kimball D., Munabi A. K., Cassorla F., Loriaux D. L. New evidence for a direct effect of prolactin on rat adrenal steroidogenesis. Endocrine Res. 1987; 13: 317–33
   PubMed Web of Science ®Google Scholar
• O'Connell T., McKenna T. J., Cunningham S. K. The effect of prolactin, human chorionic gonadotropin, insulin and insulin-like growth factor I on adrenal steroidogenesis in isolated guinea-pig adrenal cells. J. Steroid Biochem. Mol. Biol. 1994; 48: 235–40
   Google Scholar
• McCann S. M., Pan G., Xu R. J., Martinovic J., Rettori V. Modulatory hypothalamic action of ACTH on ACTH and prolactin release. Prolactin Gene Family and its Receptors, K. Hoshino. Elsevier Science Publishers B. V., Biomedical Division, Amsterdam 1988; 211–18
   Google Scholar
• Schulte H. M., Chrousos G. P., Gold P. W., Oldfield E. H., Hoban M. C., Cutler G. B., Loriaux D. L. Corticotropin-releasing factor (CRF): a common link between anterior pituitary and sympathetic responses to stress. Acta Endocrinol. (Copenh.) 1983; 102: 32–3
   Google Scholar
• Yamaji T., Ishibashi M., Teramoto A., Fukushima T. Hyperprolactinemia in Cushing's disease and Nelson's syndrome. J. Clin. Endocrinol. Metab. 1984; 58: 790–5
   Google Scholar
• Luton J. P., Molinie P., Stauch G., Guilhaume B., Bricaire H. Etude de la TSH et de la prolactine a l'etat de base et sous TRH au cours des syndromes de Cushing et de Nelson. Seminaires de l'Hopital de Paris 1981; 17-18: 841–9
   Google Scholar
• Colao A., Merola B., Spaziante R., La Tessa G., Boudouresque F., Oliver C., Lombardi G. Adrenocorticotropic hormone and b˜-endorphin concentrations in the inferior petrosal sinuses in Cushing's disease and other pituitary diseases. J. Endocrinol. Invest. 1992; 15: 807–13
   Google Scholar
• Allolio B., Günther R. W., Benker G., Reinwein D., Winkelmann W., Schulte H. M. A multihormonal response to corticotropin-releasing hormone in inferior petrosal sinus blood of patients with Cushing's disease. J. Clin. Endocrinol. Metab. 1990; 71: 1195–201
   PubMed Web of Science ®Google Scholar
• Vignati F., Berselli M. E., Scialfa G., Boccardi E., Loli P. Bilateral and simultaneous venous sampling of inferior petrosal sinuses for ACTH and prolactin determination: preoperative localization of ACTH-secreting microadenomas. J. Endocrinol. Invest. 1989; 12: 235–8
   Google Scholar
• Wiedmann K., Herzog L., Kellner M. Atrial natriuretic hormone inhibits corticotropin-releasing hormone-induced prolactin release in man. J. Psychiatr. Res. 1995; 29: 51–8
   Google Scholar
• Sapun-Malcom D., Farah J. M., Jr., Mueller G. P. Serotonin and dopamine independently regulate pituitary b˜-endorphin release in vivo. Neuroendocrinology 1986; 42: 191–6
   Google Scholar
• Farah J. M., Jr, Mueller G. P. A D-2 dopaminergic agonist stimulates secretion of anterior pituitary immunoreactive b˜-endorphin in rats. Neuroendocrinology 1989; 50: 26–32
   Google Scholar
• Nishida S., Matsuki M., Nagase Y., Horino M., Endoh M., Kakita K., Tenku A., Oyama H. Stress-mediated effect of metoclopramide on Cortisol secretion in man. J. Clin. Endocrinol. Metab. 1983; 56: 839–43
   Google Scholar
• Ghigo E., Goffi S., Molinatti G. M., Camanni F., Massara F. Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinemic women after dopamine synthesis blockade. Clin. Endocrinol. 1985; 23: 155–60
   Google Scholar
• Kovacs K., Use G., Ryan M. Pituitary prolactin cell hyperplasia. Horm. Res. 1980; 12: 87–95
   Google Scholar
• Rodriguez-Arnao M. D., Peters J. R., Foord S. M., Dieguez C., Edwards C., Gomez-Pan A., Hall R., Newcombe R. G., Scanlon M. F. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect. J. Clin. Endocrinol. Metab. 1983; 57: 975–80
   Google Scholar
• Paradisi R., Grossi G., Pintore A., Venturoli S., Porcu E., Capelli M., Flamigni C. Evidence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia. Acta Endocrinol. (Copenh.) 1991; 125: 246–52
   Google Scholar
• Nicoletti I., Filipponi P., Fedeli L., Ambrosi F., Giammartino C., Spinozzi F., Santeusanio F. Catecholamines and pituitary function. IV. Effects of low-dose dopamine infusion and long-term bromocriptine treatment on the abnormal thyrotroph (TSH) dynamics in patients with pathological hyperprolactinemia. Acta Endocrinol. (Copenh.) 1986; 111: 154–61
   Google Scholar
• Bansal S., Lee L. A., Woolf P. D. Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patients. Am. J. Med. 1981; 71: 961–6
   PubMedGoogle Scholar
• Connell J. M. C., Padfield P. L., Bunting E. A., Ball S. G., Inglis G. C., Beastall G. H., Teasdale G. M., Davies D. L. Inhibition of prolactin secretion by low-dose dopamine infusion in patients with hyperprolactinemia. Clin. Endocrinol. 1983; 18: 527–32
   PubMedGoogle Scholar
• Maraschini C., Moro M., Toja P., Braga M., Cavagnini F. No difference between micro- and macroprolactinomas in the prolactin responsiveness to metoclopramide and dopamine administration. Gynecol. Endocrinol. 1996; 10: 7–15
   Web of Science ®Google Scholar
• Kemppainen R. J., Zerbe C. A., Sartin J. L. Regulation and secretion of proopiomelanocortin peptides from isolated perfused dog pituitary pars intermedia cells. Endocrinology 1989; 124: 2208–17
   Google Scholar
• Kemppainen R. J., Sartin J. L. in vivo evidence for dopaminergic regulation of the canine pituitary intermediate lobe. Acta Endocrinol. (Copenh.) 1986; 113: 471–8
   Google Scholar
• Haas D. A., George S. R. Effect of dopaminergic and alpha-adrenergic modulation on corticotropin-releasing factor immunoreactivity in rat hypothalamus. Can. J. Physiol. Pharmacol. 1988; 66: 754–61
   Google Scholar
• Plotsky P. M., Cunningham S. K., Widmaier E. P. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorti-cotropin secretion. Endocrin. Rev. 1996; 10: 437–58
   Google Scholar
• Rots N. Y., Cools A. R., Oitzl M. S., Dejong J., Sutanto W., DeKloet E. R. Divergent prolactin and pituitary-adrenal activity in rats selectively bred for different dopamine responsiveness. Endocrinology 1996; 137: 1678–86
   Google Scholar
• Nishida S., Matsuki M., Adachi N., Horino M., Yoneda M., Endoh M., Oyama H., Kikuoka M., Otsuka R., Ishii R., Andoh C. Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adreno-corticotropin secretion. J. Clin. Endocrinol. Metab. 1987; 64: 995–1001
   Google Scholar
• Boesgaard S., Hagen C., Nyboe Andersen A., Fenger M., Eldrup E. Effect of dopamine, dopamine D-l and D-2 receptor modulation on ACTH and Cortisol levels in normal men and women. Acta Endocrinol. (Copenh.) 1990; 122: 29–36
   PubMedGoogle Scholar
• Boesgaard S., Hagen C., Nyboe Andersen A., Djursing H., Fenger M. Cortisol secretion in patients with normoprolactinemic amenorrhea. Acta Endocrinol. (Copenh.) 1988; 118: 544–50
   Google Scholar
• Murburg M. M., Wilkinson C. W., Raskind M. A., Veith R. C., Dorsa D. M. Evidence for two differentially regulated populations of peripheral p-endorphin-releasing cells in humans. J. Clin. Endocrinol. Metab. 1993; 77: 1033–40
   Google Scholar
• Zerbe C. A., Clark T. P., Sartin J. L., Kemppainen R. J. Domperidone treatment enhances corticotropin-releasing hormone stimulated adrenocorticotropic hormone release from the dog pituitary. Neuroendocrinology 1993; 57: 282–8
   Google Scholar
• Staessen J., Fiocchi R., Bouillon R., Fagard R., Lijnen P., Lissens W., Amery A. Differential responses of plasma aldosterone, Cortisol and adrenocorticotropin to two dopamine receptor antagonists. Meth. Find. Exp. Clin. Pharmacol. 1994; 7: 523–7
   Google Scholar
• Seki K. Variability of Cortisol and adrenocorticotropic hormone responses to metoclopramide during the menstrual cycle. Gynecol. Obstet. Invest. 1989; 27: 201–3
   Google Scholar
• Seki K., Mitsui C., Nagata I. Effects of a dopamine antagonist (metoclopramide) on the release of beta-endorphin, ACTH and Cortisol in hyperprolactinemic-amenorrheic women. Gynecol. Obstet. Invest. 1995; 40: 42–5
   Google Scholar
• Ciccarelli E., Faccani G., Longo A., Dalle Ore G., Papotti M., Grottoli S., Razzore P., Ghe C., Muccioli G. Prolactin receptors in human pituitary adenomas. Clin. Endocrinol. 1995; 42: 487–91
   Google Scholar
• Hugues J. N., Modigliani E., Girard F., Sebaoun J. Lack of prolactin involvement in corticosteroid secretion. J. Endocrinol. Invest. 1987; 10: 15–20
   Google Scholar
• Clapp D. H., Wiebe R. H. The effect of hyperprolactinemia on the diurnal variation of adrenal androgens. Fertil. Steril 1983; 39: 749–52
   Google Scholar
• Carter J. N., Tyson J. E., Warne G. L., McNeilly A. S., Faiman C., Friesen H. G. Adrenocortical function in hyperprolactinemic women. J. Clin. Endocrinol. Metab. 1977; 45: 973–80
   PubMed Web of Science ®Google Scholar